Comparison of cold biopsy forceps vs cold snare for diminutive colorectal polyp removal: A multicenter non-inferiority randomized controlled trial

医学 息肉切除术 结肠镜检查 随机化 镊子 粘膜切除术 随机对照试验 外科 活检 不利影响 临床终点 结直肠癌 胃肠病学 内科学 切除术 癌症
作者
Guillaume Perrod,Enrique Pérez‐Cuadrado‐Robles,Emmanuel Coron,Mathieu Pioche,Aymeric Becq,Nicolas Etchepare,David Danan,Nicolas Musquer,Xavier Dray,A. Laquière,Bénédicte Jaïs,Chloé Broudin,Hédi Benosman,Christophe Cellier,Gabriel Rahmi
出处
期刊:Clinics and Research in Hepatology and Gastroenterology [Elsevier BV]
卷期号:46 (3): 101867-101867 被引量:6
标识
DOI:10.1016/j.clinre.2022.101867
摘要

European guidelines recommends the use of cold snare polypectomy (CSP) for removal of diminutive colorectal polyps (DCP). However, for DCP < 4 mm cold biopsy forceps (CBF) may be optional. We aimed to compare the efficacy of CSP with CBF for removal of DCP in routine colonoscopy.We conducted a multicenter non-inferiority randomized controlled trial. After screening, 123 patients were prospectively included and 180 DCPs were removed by either CBF or CSP after randomization (1:1). The primary end-point was the histological complete resection rate defined by negative additional biopsies taken from the edge of the polypectomy ulcer site.Among DCPs, 121 (67.2%) adenomas or sessile serrated lesions were considered for the analysis. Polyps were 4 [1-5] mm in size, mostly flat (55.4%) and located in the proximal colon (44.6%). The en bloc resection rate was higher in the CSP group than the CBF group (91.7% vs. 42.6%, p < 0.001). The histological complete resection rate was comparable in the two groups (93.33% vs 90.16%; p = 0.527), even for polyps < 4 mm (91.30% vs 91.30%; p = 1). All specimens were retrieved and there was no difference in terms of procedure times and adverse events. Finally, univariate analysis did not identify any potential factor associated with complete resection rate.In this study, CSP was comparable to CBF for the removal of DCP. Therefore, CBF may be considered as an alternative technique for resection of DCP, together with CSP, ClinicalTrials.gov registry (NCT04727918).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Owen应助bxw采纳,获得10
1秒前
2秒前
bkagyin应助天雨流芳采纳,获得10
2秒前
dorken发布了新的文献求助10
3秒前
星辰大海应助grm采纳,获得10
3秒前
酷波er应助momomomo123采纳,获得10
3秒前
独特草莓发布了新的文献求助10
3秒前
夜绒枭完成签到 ,获得积分10
3秒前
可爱的函函应助en采纳,获得10
5秒前
小舒发布了新的文献求助10
5秒前
完美世界应助1234采纳,获得10
5秒前
5秒前
大力的灵雁应助星河入梦采纳,获得10
6秒前
7秒前
7秒前
艾西元发布了新的文献求助10
7秒前
鲤鱼笑阳完成签到 ,获得积分10
8秒前
赢赢完成签到 ,获得积分10
8秒前
窦昊完成签到,获得积分10
9秒前
10秒前
科研通AI6.3应助LiuMeng采纳,获得10
11秒前
星期八完成签到,获得积分10
12秒前
12秒前
13秒前
下一周完成签到,获得积分10
13秒前
jiang qinqin发布了新的文献求助10
13秒前
CipherSage应助CMUSK采纳,获得10
13秒前
14秒前
14秒前
科目三应助fanfan采纳,获得10
15秒前
xxxxffff完成签到,获得积分10
15秒前
dong发布了新的文献求助10
16秒前
超能力完成签到,获得积分20
17秒前
zhr发布了新的文献求助10
18秒前
英俊的铭应助3118472087采纳,获得10
18秒前
CipherSage应助喜悦桥采纳,获得10
19秒前
乐观秋荷应助槐序深巷采纳,获得10
19秒前
1234发布了新的文献求助10
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1500
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Rheumatoid arthritis drugs market analysis North America, Europe, Asia, Rest of world (ROW)-US, UK, Germany, France, China-size and Forecast 2024-2028 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6366180
求助须知:如何正确求助?哪些是违规求助? 8180082
关于积分的说明 17244573
捐赠科研通 5420962
什么是DOI,文献DOI怎么找? 2868279
邀请新用户注册赠送积分活动 1845413
关于科研通互助平台的介绍 1692909